Affymetrix Recalls CytoScan Dx Assay Kits Due to Missing Warning Statements
Affymetrix is recalling 507 CytoScan Dx Assay kits because FDA inspectors found that required warning statements were missing from product shipments.
The agency’s classification
FDA (Devices): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The agency classified this as a Class III recall, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences. The issue is a documentation/packaging error (missing warning statements) rather than a direct physical hazard.
Plain-English summary
Affymetrix Inc is recalling 507 kits of the CytoScan Dx Assay. The recall was initiated after a recent FDA site inspection in Ohio revealed that warning statements needed to be included with the product shipment but were missing.
The affected product consists of five reagent modules, wash buffers, a microarray kit, and analysis software. The kits were distributed in the US to the states of AR, CA, DC, MI, MA, MN, NC, NM, NY, PA, SC, TN, TX, WA, and WV.
The agency has classified this recall as Class III, indicating that use of or exposure to the violative product is not likely to cause adverse health consequences. Users should stop using the affected kits and contact Affymetrix for instructions on return or replacement.
The recalled product
- Product
- CytoScan¿ Dx Assay. The CytoScan Dx Assay consists of five reagent modules, wash buffers (WS), a microarray kit, and analysis software. The CytoScan Dx Assay consists of five reagent modules, wash buffers (WS), a microarray kit, and analysis software: MOD R LA, CytoScan¿ Dx…
- Manufacturer
- Affymetrix Inc
- Hazard
- Affected units
- 507
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- 4044094 exp 6/10/17
- 4044095 exp 6/10/17
- 4044148 exp 10/14/17
- 4044149 exp 10/14/17
- 4044150 exp 12/17/17
- 4044151 exp 12/17/17
Distribution
Related recalls
Same hazard · missing warning label
See all →- Moderate
- High
- High
- HighPortable bed rails recalled over entrapment and asphyxiation hazards
CPSC · 2025-12-18
- HighOshkosh Recalls 2025 NGDV Vehicles for Detaching Air Bag Warning Label
NHTSA · 2025-06-27
Similar recalls
- ModerateCystatin C Diagnostic Reagent Marketed Without FDA 510(k) Clearance
FDA (Devices) · 2024-07-31
- LowHemoCue Urine Analyzer Recall for Missing Documentation
FDA (Devices) · 2013-01-09
- HighClinical analyzer modules recalled over dilution factor software anomaly affecting results
FDA (Devices) · 2025-10-29
- ModerateBeckman Coulter Recalls DxC 500i Clinical Analyzer Modules Due to Software Error
FDA (Devices) · 2026-10-14
- HighBeckman Coulter DxC 500 AU Analyzer Software Defect Recall
FDA (Devices) · 2026-08-26
- LowApotex Recalls Candesartan Cilexetil Tablets Due to Impurity Failures
FDA (Drugs) · 2014-11-12